Browse by outcome
Choose an intervention dossier to evaluate the supplied synthesis and supporting evidence.
This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.
5 of 5 dossiers shown
Semaglutide → Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)
Semaglutide shows a strong positive evidence signal for improving Composite cardiovascular events (CV death, MI, stroke, HF hospitalization) across the studied comparisons.
Semaglutide → Nonfatal stroke
Semaglutide does not show benefit for Nonfatal stroke in the available evidence and may be associated with worse results.
Semaglutide → Cardiovascular events
Semaglutide shows a strong positive evidence signal for improving Cardiovascular events across the studied comparisons.
Semaglutide → All-cause mortality
Semaglutide has a small positive evidence signal for All-cause mortality, but the clinical interpretation is limited.
Semaglutide → Cardiovascular death
Semaglutide does not show benefit for Cardiovascular death in the available evidence and may be associated with worse results.
